Exhibit 99.2

VCA Antech, Inc. Provides Financial Guidance

    LOS ANGELES--(BUSINESS WIRE)--Oct. 26, 2004--VCA Antech, Inc.
(Nasdaq:WOOF), a leading animal health care company in the United
States, provides the following guidance for all investors in adherence
with Regulation Fair Disclosure as issued by the United States
Securities and Exchange Commission, SEC, and encourages all current
and potential investors to review the disclosure regarding
forward-looking statements in this press release as well as in all
financial documents filed with the SEC. All guidance amounts are
before any potential special items.
    VCA Antech, Inc. is providing the following financial guidance for
the three months ending December 31, 2004:

    --  Revenue to a range of $168.0 million to $171.0 million.

    --  Diluted earnings per common share of $0.14.

    VCA Antech, Inc. is providing the following preliminary financial
guidance for the year ending December 31, 2005:

    --  Revenue to a range of $771.0 million to $785.0 million.

    --  Diluted earnings per common share to a range of $0.86 to
        $0.88, which excludes the potential impact of proposed changes
        in accounting for stock-based compensation for which a final
        standard has not been issued by the Financial Accounting
        Standards Board.

    Statements contained in this release that are not based on
historical information are forward-looking statements that involve
risks and uncertainties. Actual results may vary substantially as a
result of a variety of factors. Among the important factors that could
cause actual results to differ are the level of direct costs and the
ability of the Company to maintain revenue at a level necessary to
maintain expected operating margins, the level of selling, general and
administrative costs, the effects of competition, the effects of the
Company's recent acquisitions and its ability to effectively manage
its growth, the ability of the Company to service its debt, the
continued implementation of the Company's management information
systems, pending litigation and governmental investigations, general
economic conditions, and the results of the Company's acquisition
program. These and other risk factors are discussed in the Company's
recent filings with the Securities and Exchange Commission on Form
10-K and Form 10-Q and the reader is directed to these statements for
a further discussion of important factors that could cause actual
results to differ materially from those in the forward-looking
statements.

    VCA Antech owns, operates and manages the largest networks of
freestanding veterinary hospitals and veterinary-exclusive clinical
laboratories in the country.

    CONTACT: VCA Antech, Inc.
             Tom Fuller, 310-571-6505